ExodusPoint Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-68,910
Closed -$2.9M 2274
2023
Q2
$2.9M Sell
68,910
-8,425
-11% -$341K 0.02% 659
2023
Q1
$2.75M Buy
+77,335
New +$2.81M 0.02% 752
2022
Q4
Sell
-92,318
Closed -$4.35M 2277
2022
Q3
$4.35M Buy
92,318
+48,972
+113% +$3.16M 0.06% 455
2022
Q2
$3.11M Buy
43,346
+15,334
+55% +$1.12M 0.04% 594
2022
Q1
$2.27M Buy
+28,012
New +$2.37M 0.03% 715
2021
Q4
Sell
-13,331
Closed -$1.17M 2736
2021
Q3
$1.17M Buy
+13,331
New +$1.21M 0.02% 959
2021
Q1
Sell
-50,742
Closed -$3.46M 2730
2020
Q4
$3.46M Buy
50,742
+27,498
+118% +$1.71M 0.03% 355
2020
Q3
$1.24M Sell
23,244
-60,344
-72% -$3.59M 0.02% 603
2020
Q2
$4.87M Buy
83,588
+65,431
+360% +$3.52M 0.13% 165
2020
Q1
$716K Buy
18,157
+7,818
+76% +$457K 0.04% 381
2019
Q4
$615K Buy
+10,339
New +$556K 0.01% 758
2019
Q2
Sell
-17,938
Closed -$928K 1395
2019
Q1
$928K Buy
+17,938
New +$870K 0.07% 198

Other funds holding SYNH

ExodusPoint Capital Management's SYNH Position: Q3 2023 in Review

ExodusPoint Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 68,910 shares — an estimated $2.9M sold.

ExodusPoint Capital Management first reported a position in SYNH in Q1 2019 and held it in 12 quarters. The position peaked at $4.87M in Q2 2020. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • ExodusPoint Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • ExodusPoint Capital Management sold 68,910 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $2.9M.
  • ExodusPoint Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2019 and held it in 12 quarters.
  • ExodusPoint Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $4.87M in Q2 2020.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on ExodusPoint Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.